Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication
Uusitalo H., Chen E., Pfeiffer N., Brignole-Baudouin F., Kaarniranta K., Leino M., Puska P., Palmgren E., Hamacher T., Hofmann G., Petzold G., Richter U., Riedel T., Winter M., Ropo A.
View publication
-
Therapeutic Area
Glaucoma
-
Categories
Clinical development
-
Affiliations
University of Tampere, Tampere University Hospital, Tampere, Finland; St Erik Eye Hospital, Stockholm, Sweden; Augenklinik der Joh.-Gutenberg- Universität Mainz, Mainz, Germany; Department of Toxicology, University Paris Descartes, University Paris 6, Paris, France; University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland; Kuopion Näkökeskus, Kuopio, Finland; Helsingin Lääkärikeskus, Helsinki, Finland; Nyköpings Lasarett, Nyköping, Sweden; Praxis Starnberg, Starnberg, Germany; Praxis Schweinfurt, Schweinfurt, Germany; Praxis Kulmbach, Kulmbach, Germany; Praxis Regensburg, Regensburg, Germany; Praxis Dresden, Dresden, Germany; Praxis Bremen, Bremen, Germany; Santen Oy, Tampere, Finland